HomeCompareJCDXY vs JNJ

JCDXY vs JNJ: Dividend Comparison 2026

JCDXY yields 3.34% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JCDXY wins by $710.52M in total portfolio value
10 years
JCDXY
JCDXY
● Live price
3.34%
Share price
$9.31
Annual div
$0.31
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$710.55M
Annual income
$671,919,978.97
Full JCDXY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — JCDXY vs JNJ

📍 JCDXY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJCDXYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JCDXY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JCDXY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JCDXY
Annual income on $10K today (after 15% tax)
$284.04/yr
After 10yr DRIP, annual income (after tax)
$571,131,982.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JCDXY beats the other by $571,127,996.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JCDXY + JNJ for your $10,000?

JCDXY: 50%JNJ: 50%
100% JNJ50/50100% JCDXY
Portfolio after 10yr
$355.29M
Annual income
$335,962,334.18/yr
Blended yield
94.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JCDXY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.0
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JCDXY buys
0
JNJ buys
0
No recent congressional trades found for JCDXY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJCDXYJNJ
Forward yield3.34%2.13%
Annual dividend / share$0.31$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$710.55M$30.3K
Annual income after 10y$671,919,978.97$4,689.40
Total dividends collected$707.73M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: JCDXY vs JNJ ($10,000, DRIP)

YearJCDXY PortfolioJCDXY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,368$668.34$10,592$272.30+$776.00JCDXY
2$13,584$1,420.16$11,289$357.73+$2.3KJCDXY
3$17,707$3,171.93$12,123$472.89+$5.6KJCDXY
4$26,675$7,728.24$13,141$629.86+$13.5KJCDXY
5$50,303$21,761.11$14,408$846.81+$35.9KJCDXY
6$130,529$76,704.51$16,021$1,151.60+$114.5KJCDXY
7$511,696$372,030.34$18,122$1,588.22+$493.6KJCDXY
8$3,273,542$2,726,026.52$20,930$2,228.20+$3.25MJCDXY
9$36,100,009$32,597,319.31$24,792$3,191.91+$36.08MJCDXY
10$710,546,988$671,919,978.97$30,274$4,689.40+$710.52MJCDXY

JCDXY vs JNJ: Complete Analysis 2026

JCDXYStock

JCDecaux SE engages in the outdoor advertising activities worldwide. It operates through three segments: Street Furniture, Transport, and Billboard. The Street Furniture segment is involved in advertising in shopping malls; renting of street furniture; selling and renting of equipment; and the provision of cleaning, maintenance, and other activities. The Transport segment provides advertising services in public transport systems, such as airports, metros, buses, tramways, and trains. The Billboard segment is involved in advertising on private property, including traditional large format or back-light billboards; and the provision of neon-light billboards and advertising wraps. The company was founded in 1964 and is based in Neuilly-sur-Seine, France. JCDecaux SE is a subsidiary of JCDecaux Holding SAS.

Full JCDXY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this JCDXY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JCDXY vs SCHDJCDXY vs JEPIJCDXY vs OJCDXY vs KOJCDXY vs MAINJCDXY vs ABBVJCDXY vs MRKJCDXY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.